2011
Happiness, I want more! From the alleys of Nigeria and the beaches of California to the mountains of India, ordinary young people lead us on an extraordinary journey to explore the nature of lasting happiness and end up starting a movement.
62 min
CLEAR ALL
Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
1
A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.
3
The new research looked at cancer patients who took part in a study nearly five years ago.
Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.
To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.
Ketamine is a controversial yet effective treatment in psychiatry, and it arrives at a much needed time as depression and suicide rates have reached crisis levels in the United States.
In this webinar, Dr. Sanjay Mathew will review the history of ketamine for the treatment of serious depressive disorders and other similar treatments in development.
A new generation of research into psilocybin could change how we treat numerous mental health conditions.
The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.